Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways-Reference-Cited by-同舟云学术

Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways

Published:2020-08-12 Issue:5 Volume:28 Page:1407-1420
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Elbaz Eman M.^ORCID,Amin Hebat Allah A.,Kamel Ahmed S.^ORCID,Ibrahim Sherehan M.,Helmy Hebatullah S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-020-00743-1.pdf

Reference78 articles.

1. Afdal A, Darwin E, Yanwirasti Y, Hamid R (2019) The expression of transforming growth factor beta-1 and interleukin-6 on human prostate: prostate hyperplasia and prostate cancer. Open Access Maced J Med Sci 7:1905–1910. https://doi.org/10.3889/oamjms.2019.548

2. Altavilla D, Minutoli L, Polito F et al (2012) Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. Br J Pharmacol 167:95–108. https://doi.org/10.1111/j.1476-5381.2012.01969.x

3. Ammar AE, Esmat A, Hassona MDH et al (2015) The effect of pomegranate fruit extract on testosterone-induced BPH in rats. Prostate 75:679–692. https://doi.org/10.1002/pros.22951

4. Andriole G, Bruchovsky N, Chung LWK et al (2004) Dihydrotestosterone and the prostate: the scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol 172:1399–1403. https://doi.org/10.1097/01.JU.0000139539.94828.29

5. Arunkumar R, Sharmila G, Elumalai P et al (2012) Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis. Phytomedicine 19:912–923. https://doi.org/10.1016/j.phymed.2012.04.009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asiatic acid mitigates testosterone-induced benign prostatic hyperplasia in rats via activation of PPAR-γ;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-02

2. Plausible role of oral Fisetin-loaded chitosan oligosaccharide nanoparticles in amelioration of benign prostatic hypertrophy: In vitro and in vivo assessments;Journal of Drug Delivery Science and Technology;2024-03

3. Assessment of the in-vitro toxicity and in-vivo therapeutic capabilities of Juglans regia on human prostate cancer and prostatic hyperplasia in rats;Food Bioscience;2024-02

4. Investigating the therapeutic potential of sinomenine in rheumatoid arthritis: anti-inflammatory, antioxidant, and immunomodulatory mechanisms;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-22

5. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations;European Journal of Pharmacology;2023-10